CSL buys stem cell therapy firm Calimmune – SBS
|
CSL buys stem cell therapy firm Calimmune
SBS The acquisition will provide CSL Behring, CSL's blood products business, with Calimmune's haematopoietic stem cell gene therapy which is being developed for the treatment of sickle cell disease and b-thalassemia. The deal requires an an up-front … |
